Concepedia

Publication | Closed Access

Long-term safety and efficacy of erenumab in patients with chronic migraine: Results from a 52-week, open-label extension study

DOI

98

Citations

11

References

2020

Year

Stewart J. Tepper, Messoud Ashina, Uwe Reuter, Jan Lewis Brandes, David Doležil, Stephen D. Silberstein, Paul Winner, Sunfa Cheng, Daniel D. Mikol
Cephalalgia

Abstract

This study is registered at ClinicalTrials.gov (NCT02174861).

References

YearCitations

Page 1